. 2018 Feb 5;9:157. doi: 10.3389/fimmu.2018.00157

Table 6.

Expression of various Treg, Th17 markers, and their cellular subsets (those showing significance) in terms of their absolute number and percentages during recruitment of study subjects.

Markers/subsets		PTB (n = 15)	NHS (n = 17)
CD25	Ab. no.	221.2 ± 25.64	26.82 ± 5.27
CD25	%	13.10 ± 1.51	1.55 ± 0.30

IL-17A	Ab. no.	85.00 ± 17.39	245.30 ± 30.40
IL-17A	%	4.92 ± 1.00	14.18 ± 1.75

CD4⁺CD25⁺	Ab. no.	225.5 ± 26.22	16.71 ± 2.76
CD4⁺CD25⁺	%	13.03 ± 1.52	0.98 ± 0.16

CD4⁺CD39⁺	Ab. no.	59.67 ± 15.25	17.29 ± 2.97
CD4⁺CD39⁺	%	3.45 ± 0.88	0.99 ± 0.17

CD4⁺CD127⁺	Ab. no.	375.7 ± 44.05	246.7 ± 41.13
CD4⁺CD127⁺	%	21.72 ± 2.55	14.26 ± 2.38

CD4⁺IL-17A	Ab. no.	56.66 ± 10.97	199.4 ± 27.22
CD4⁺IL-17A	%	3.27 ± 0.63	11.52 ± 1.58

CD4⁺CD25⁺Foxp3	Ab. no.	69.80 ± 13.59	15.29 ± 2.63
CD4⁺CD25⁺Foxp3	%	9.79 ± 1.37	2.48 ± 0.45

CD4⁺CD25⁺CD39⁺	Ab. no.	20.67 ± 4.63	5.47 ± 1.26
CD4⁺CD25⁺CD39⁺	%	3.77 ± 0.68	1.04 ± 0.23

PTB, pulmonary tuberculosis patients; NHS, normal healthy subjects; %, percentages; Ab. no., absolute number.

The values represented in the above table are mean ± SEM.